Suchergebnisse - "Domingo-Domenech, Eva"

PubPharm (16)

1

Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL) : real-life experience with long-term outcomes, toxicities and responses to second-line therapies

enthalten in: International journal of hematology | 2023

von Oliveira, A. | Roncero, J. | Ferrá, C. | +10

2

Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients

enthalten in: Annals of hematology | 2021

von González-Barca, E. | Capote, F. | Gómez-Codina, J. | +11

3

Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas : Data from the Spanish Primary Cutaneous Lymphoma Registry

enthalten in: Journal of the American Academy of Dermatology | 2020

von Muniesa, C. | Domingo-Domenech, E. | Fornons-Servent, R. | +16

4

Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients

enthalten in: Annals of hematology | 2020

von González-Barca, E. | Capote, F. | Gómez-Codina, J. | +10

5

Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients

enthalten in: Annals of hematology | 2020

von González-Barca, E. | Capote, F. | Gómez-Codina, J. | +10

6

Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients

enthalten in: Annals of hematology | 2020

von González-Barca, E. | Capote, F. | Gómez-Codina, J. | +10

7

Validation of the NCCN-IPI and the GELTAMO-IPI for diffuse large B-Cell lymphoma treated with R-CHOP in a large cohort of patients from a single institution

enthalten in: Leukemia & lymphoma | 2020

von Salas, M. | Mercadal, S. | Domingo Domenech, E. | +8

8

Clinicopathologic features and prognostic significance of CD30 expression in de novo diffuse large B-cell lymphoma (DLBCL) : results in a homogeneous series from a single institution

enthalten in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals | 2020

von Salas, M. | Climent, F. | Tapia, G. | +12

9

Refractoriness to rituximab-based therapy and elevated serum B2-microglobulin predict for inferior survival in marginal zone lymphoma

enthalten in: Leukemia & lymphoma | 2019

von Sorigue, M. | Bishton, M. | Domingo-Domenech, E. | +10

10

Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma

enthalten in: Blood | 2017

von Salar, A. | Domingo-Domenech, E. | Panizo, C. | +18